« Older Entries

Meet our Editorial Board member, Alexandros Sofias

07 Aug 2026
By .

We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Dr Alexandros Sofias. He is also an Associate Editor and will handle all review submissions to RSC Pharmaceutics.

Dr Alexandros Sofias is the head of the “Immune Cell Targeting and Imaging” laboratory at the Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, Germany. His research focuses on unraveling the intricate in vivo fate of cancer nanomedicine using multimodal and multiscale imaging techniques, and developing nanoimmunotherapeutics for targeting and manipulating the cancer-associated immune system in the tumor microenvironment, circulation, and hematopoietic organs.  

His lab is funded by the prestigious JPI Fellowship from the Excellence Initiative of the German Research Foundation (DFG), as well as research grants from the German Cancer Aid (Krebshilfe), the Clinical Research Unit (CRU) program of the German Research Foundation (DFG, CRU 344), the START Program (Faculty of Medicine, RWTH), and the Euro-Bioimaging. He also serves as Conference Chair for the Controlled Release Society (CRS) 2027 Annual Meeting (Toronto, 12-15 July 2027), Elected Member of the European Society for Molecular Imaging (ESMI) Governing Board, and Editorial Board Member for Advanced Drug Delivery Reviews (ADDR) and npj Imaging.

Read some of Dr Alexandros Sofias’s work here:

Neutrophil Hitchhiking Enhances Liposomal Dexamethasone Therapy of Sepsis
Ritvik Mathur, Sara Elsafy, Adrian T Press, Julian Brück, Mathias Hornef, Lukas Martin, Tobias Schürholz, Gernot Marx, Matthias Bartneck, Fabian Kiessling, Josbert Maarten Metselaar, Gert Storm, Twan Lammers, Alexandros Marios Sofias, Patrick Koczera
ACS Nano, 2024, 18, 28866

Intravital microscopy for real-time monitoring of drug delivery and nanobiological processes
Jeffrey Momoh, Dimitrios Kapsokalyvas, Michael Vogt, Sjoerd Hak, Fabian Kiessling, Marc van Zandvoort, Twan Lammers, Alexandros Marios Sofias
Adv. Drug Delivery Rev., 2022, 189, 114528

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.

Comments Off on Meet our Editorial Board member, Alexandros Sofias

5th South Florida Translational Research Symposium – RSC Pharmaceutics Poster Prize Winners

15 May 2026
By .

The FIU Center for Translational Science 5th Annual South Florida Translational Research Symposium took place at Florida International University, USA, on the 9th and 10th of April 2026. The symposium featured excellent plenary talks on congenital heart disease, lung injury, stroke, and bench to bedside research. Our RSC Pharmaceutics Editorial Member, Dr Heidi Mansour attended this conference, and RSC Pharmaceutics was delighted to sponsor four prizes for the undergraduate, medical student, post graduate and postdoctoral poster winners:

Undergraduate poster winner: Carleigh Miller (Nova Southeastern University)

Medical student poster winner: Oren Nedjar (Nova Southeastern University)

Graduate poster winner: Joseph Souchak (Florida International University)

Postdoctoral poster winner: Hasham Shafi (Florida International University)

We are delighted that the symposium was such a success and we would like to wish a huge congratulations to the poster prize winners!

Dr. Benedict Albensi and Dr. Stephen M. Black  Joseph Souchak and Dr. Stephen M. Black  Dr. Hasham Shafi and Dr. Stephen M. Black [Left] Prof. Benedict Albensi from Nova Southeastern University on behalf of Carleigh Miller and Oren Nedjar, and Prof. Stephen M. Black from Florida International University. Not pictured: Carleigh Miller, Undergraduate Poster Winner, and Oren Nedjar, Medical Student Poster Winner. [Middle] Joseph Souchak, Graduate Poster Winner. [Right] Hasham Shafi, Postdoctoral Fellow Poster Winner.

RSC Pharmaceutics

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Submit to RSC Pharmaceutics today!

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

Comments Off on 5th South Florida Translational Research Symposium – RSC Pharmaceutics Poster Prize Winners

Meet our Advisory Board member, Defang Ouyang

14 May 2026
By .

We are delighted to introduce you to our new RSC Pharmaceutics Advisory Board member, Dr Defang Ouyang.

Dr Defang Ouyang is an Associate Professor at the University of Macau. Since 2011, he has pioneered the integration of artificial intelligence, big data and multi-scale modelling techniques in the field of drug delivery.

“The Royal Society of Chemistry (RSC) is among the oldest scientific and research organizations. With a keen interest in computational pharmaceutics, I am both honoured and thrilled to be a member of RSC Pharmaceutics.” – Dr Defang Ouyang.

Dr Defang OuyangRead some of Dr Ouyang’s research:

AI-directed formulation strategy design initiates rational drug development
Nannan Wang, Jie Dong, Defang Ouyang
J. Control. Release, 2025, 378, 619-636

Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery
Wei Wang, Kepan Chen, Ting Jiang, Yiyang Wu, Zheng Wu, Hang Ying, Hang Yu, Jing Lu, Jinzhong Lin, Defang Ouyang
Nat. Commun., 2024, 15, 10804

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Submit to RSC Pharmaceutics today!

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

Comments Off on Meet our Advisory Board member, Defang Ouyang

Meet our Editorial Board member, Jessica Larsen

24 Nov 2025
By .

We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Professor Jessica Larsen.

Professor Larsen is the Carol and John ’63 Cromer Family Endowed Associate Professor, currently holding position at Clemson University.

She began her academic career at the University of Virginia, obtaining her BS in Chemical Engineering in 2012. She obtained her PhD in Chemical Engineering from Auburn University, where she was able to perform research under Drs. Mark Byrne in Chemical Engineering and Doug Martin in the College of Veterinary Medicine. Her research focuses on polymer-based nanotechnology to enable the treatment of neurologic conditions, delivering drugs across the blood-brain and blood-nerve barriers. In her undergraduate mentoring efforts, she has received the Phil and Mary Bradley Award for Mentoring in Creative Inquiry in 2020. She was also selected as the 2021 Outstanding Faculty Woman at Clemson University. She received the NSF CAREER Award in the Spring of 2021, the Governor’s Young Scientist Award for Excellence in Scientific Research in 2022, and the College of Engineering, Computing and Applied Science Junior Researcher of the Year in 2024. She has been an invited speaker at the Controlled Release Society Annual Meeting, the American Institute of Chemical Engineers Annual Meeting, and the World Biomaterials Congress. Her work has been continually funded by the NSF, NIH, and multiple disease-specific foundations since her lab’s inception in 2017.

Read some of Professor Larsen’s research:

Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges
Chloe Forenzo, Jessica Larsen
Mol. Pharmaceutics 2023, 20, 9, 4387–4403

Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery
Cara Katterman, Christopher Pierce, Jessica Larsen
ACS Appl. Bio Mater. 2021, 4, 4, 2853–2862

The characterization of self-assembled nanostructures in whole blood
Mark Pitman and Jessica Larsen
Anal. Methods, 2020, 12, 2068-2081

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.

Comments Off on Meet our Editorial Board member, Jessica Larsen

Meet our Editorial Board member, Francesca Taraballi

19 Nov 2025
By .

We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Dr Francesca Taraballi.

Dr Taraballi is currently Associate Professor, Director at the Center for Musculoskeletal Regeneration, Houston Methodist Research Institute, USA.

Dr. Francesca Taraballi is a leading expert in translational nanomedicine and immunoengineering, with a strong focus on the clinical scalability of drug delivery systems. Her research bridges material science and immunology to develop smart biomaterials for regenerative medicine and oncology. A core aspect of her work centers on the design, optimization, and GMP-compliant scale-up of nanoparticle platforms—particularly lipid-based systems—for RNA and small molecule delivery. She has extensive experience in navigating regulatory pathways and implementing manufacturing workflows for first-in-human trials, contributing to the development of hospital-based models for personalized therapeutics.

RSC Pharmaceutics Editorial Board member Dr Francesca Taraballi, Houston Methodist Research Institute

Read some of Dr Taraballi’s research:

RNA therapies for musculoskeletal conditions
Chiara Mancino, Madeline Franke, Antonietta Greco, Tarun Sontam, Patrick Mcculloch, Claudia Corbo, Francesca Taraballi
Journal of Controlled Release, 2025, 377, 756–766

Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
Chiara Mancino, Jeroen Pollet, Assaf Zinger, Kathryn M. Jones, Maria José Villar, Ana Carolina Leao, Rakesh Adhikari, Leroy Versteeg, Rakhi Tyagi Kundu, Ulrich Strych, Federica Giordano, Peter J. Hotez, Maria Elena Bottazzi, Francesca Taraballi, Cristina Poveda
ACS Applied Materials and Interfaces, 2024, 16(13), 15832–15846

Biomimetic Scaffolds Modulate the Posttraumatic Inflammatory Response in Articular Cartilage Contributing to Enhanced Neoformation of Cartilaginous Tissue In Vivo
Guillermo Bauza-Mayol, Marcos Quintela, Ava Brozovich, Michael Hopson, Shazad Shaikh, Fernando Cabrera, Aaron Shi, Federica Banche Niclot, Francesca Paradiso, Emman Combellack, Tom Jovic, Paul Rees, Ennio Tasciotti, Lewis W. Francis, Patrick Mcculloch, Francesca Taraballi
Advanced Healthcare Systems, 2022, 11(1), 2101127

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.

Comments Off on Meet our Editorial Board member, Francesca Taraballi

RSC Pharmaceutics poster prize winners at Nano DDS conference

18 Nov 2025
By .

RSC Pharmaceutics was delighted to sponsor poster prizes at the recent Nano DDS conference held at Houston Methodist Research Institute, USA. NanoDDS is the first and one of the most important conferences in nanomedicine. Established over twenty years ago by Drs. Kabanov and Kataoka, it continues to be a premier forum for showcasing cutting-edge research and emerging technologies in drug delivery systems. The conference was co-chaired this year by Dr. Biana Godin, Dr. Francesca Taraballi (RSC Pharmaceutics Editorial Board member) and Dr. Alessandro Grattoni.

 

Congratulations to all the winners:

1st prize: Joseph Cave (Houston Methodist Research Institute)

2nd prize: Danilo Settis (Houston Methodist Research Institute)

3rd prize: Ali Haghighat Mesbahi (MD Anderson Cancer Center)

4th prize: Abi Rei (Houston Methodist Research Institute)

 

Left to right: Danilo Settis (2nd place), Abe Rei (4th place), Ali Haghighat Mesbahi (3rd place), Joseph Cave (1st place), Biana Godin (co-chair, NanoDDS)

Comments Off on RSC Pharmaceutics poster prize winners at Nano DDS conference

Meet our Advisory Board member, Marianne Ashford

11 Nov 2025
By .

We are delighted to introduce you to our new RSC Pharmaceutics Advisory Board member, Dr. Marianne Ashford.

Dr. Marianne Ashford is a Senior Principal Scientist in Pharmaceutical Sciences, R&D at AstraZeneca.

Read some of Dr. Ashford’s research:

A translational framework to DELIVER nanomedicines to the clinic
Paul Joyce, Christine J. Allen, María José Alonso, Marianne Ashford, Michelle S. Bradbury, Matthieu Germain, Maria Kavallaris, Robert Langer, Twan Lammers, Maria Teresa Peracchia, Amirali Popat, Clive A. Prestidge, Cristianne J. F. Rijcken, Bruno Sarmento, Ruth B. Schmid, Avi Schroeder, Santhni Subramaniam, Chelsea R. Thorn, Kathryn A. Whitehead, Chun-Xia Zhao and Hélder A. Santos
Nat. Nanotechnol., 2024, 19, 1597

Free drug and ROS-responsive nanoparticle delivery of synergistic doxorubicin and olaparib combinations to triple negative breast cancer models
Robert J Cavanagh, Patrícia F Monteiro, Cara Moloney, Alessandra Travanut, Fatemeh Mehradnia, Vincenzo Taresco, Ruman Rahman, Stewart G Martin, Anna M Grabowska, Marianne B Ashford and Cameron Alexander
Biomater. Sci., 2024, 12, 1822

In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate
Silvia Sonzini, Fanny Caputo, Dora Mehn, Luigi Calzolai, Sven Even Borgos, Astrid Hyldbakk, Kevin Treacher, Weimin Li, Mark Jackman, Najet Mahmoudi, M Jayne Lawrence, Claire Patterson, David Owen, Marianne Ashford and Nadim Akhtar
Int. J. Pharm., 2023, 637, 122905

RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is now open for submissions.

Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.

Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.

Comments Off on Meet our Advisory Board member, Marianne Ashford

Choose your favourite cover image from our first year

25 Sep 2025
By .

Celebrate Two Years of RSC Pharmaceutics with Us!

In April 2024, RSC Pharmaceutics launched its very first issue. Since then, we’ve featured a range of striking and creative cover images that reflect the exciting research published in the journal.

We invite you to help us celebrate by voting for your favourite cover from our first year.

Vote for your favourite cover here 

 

A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model Electrostatically hindered diffusion for predictable release of encapsulated cationic antimicrobials A model binary system for the evaluation of novel ion pair formulations of diclofenac
Stanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek Viktor Eriksson, Erik Nygren, Romain Bordes, Lars Evenäs and Markus Andersson Trojer Mignon Cristofoli, Jonathan Hadgraft, Majella E. Lane and Bruno C. Sil
RSC Pharm., 2024,1, 37-46

 

 RSC Pharm., 2024,1, 47-56

 

 RSC Pharm., 2024,1, 234-244

 
Enhancement of drug permeation across skin through stratum corneum ablation Green synthesis of silver nanoparticles using Phyllanthus emblica extract: investigation of antibacterial activity and biocompatibility in vivo Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer’s disease
Ayyah Abdoh, David Liu and Yousuf Mohammed Md Monir Hossain, Amir Hamza, Shakil Ahmed Polash, Mehedi Hasan Tushar, Masato Takikawa, Anuj Bhowmik Piash, Chaitali Dekiwadia, Tanushree Saha, Shinji Takeoka and Satya Ranjan Sarker Nuruddin Mahadik, Gemma A. Barron, Paul Kong Thoo Lin and Colin J. Thompson
RSC Pharm., 2024,1, 151-160

 

 RSC Pharm., 2024,1, 245-258

 

 RSC Pharm., 2024,1, 161-181

 
Doxorubicin-Polysorbate 80 conjugates: targeting effective and sustained delivery to the brain Is receptor mediated active macrophage targeting of amphotericin B nanoformulations a promising approach? Programmable protein delivery from microgel/hydrogel composites (MHCs) via discrete combinations of multi-state protein-loaded unit ingredients
S. Ram Prasad, Sruthi Sudheendran Leena, Ani Deepthi, A. N. Resmi, Ramapurath S. Jayasree, K. S. Sandhyab and A. Jayakrishnan Saugandha Das, Pooja Todke, Manisha Madkaikar and Padma Devarajan Longfei Chen and Saif A. Khan
RSC Pharm., 2024,1, 412-429

 

 RSC Pharm., 2024,1, 430-440

 

 RSC Pharm., 2024,1, 689-704

 
Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection Structure–activity relationships of DNA nanocarriers based on the amphipathic cell penetrating peptide transportan 10
Hafsa Qadri, Asif A. Malik, Aadil A. Ahangar, Manzoor Ahmad Mir, Ajiaz A. Dar and Abdul Haseeb Shah Amalendu P. Ranjan, Daniel J. Czyzyk, Griselle Martinez-Traverso, Aygul Sadiqova, Margarita Valhondo, Deborah A. Schaefer, Krasimir A. Spasov, William L. Jorgensen, Jamboor K. Vishwanatha, Michael W. Riggs, Alejandro Castellanos-Gonzalez and Karen S. Anderson Lucas Rodrigues de Mello, Tâmisa Seeko Bandeira Honda, Sang Won Han, Valeria Castelletto, Ian William Hamley, Ly Porosk, Ülo Langel and Emerson Rodrigo da Silva
RSC Pharm., 2024,1, 705-715 RSC Pharm., 2024,1, 963-975 RSC Pharm., 2024,1, 976-993

 

Comments Off on Choose your favourite cover image from our first year

RSC Pharmaceutics Volume 2, Issue 3

21 May 2025
By .

We are delighted to share Volume 2, Issue 3 of RSC Pharmaceutics. Read our new open access journal, publishing crucial research on pharmaceutics, which has the potential to drive real change in worldwide health.

“RSC Pharmaceutics will provide a platform for researchers to showcase their best work in this field and contribute to the advancement of Pharmaceutics. I look forward to promoting this journal and its published research to the community.”

Yvonne Perrie, Editor-in-Chief, RSC Pharmaceutics

 

Here are a few of the articles featured in our latest issue:

 

Graphical abstract: AI-driven innovations in pharmaceuticals: optimizing drug discovery and industry operations

AI-driven innovations in pharmaceuticals: optimizing drug discovery and industry operations

Jaskaran Preet Singh Saini,  Ankita Thakur and Deepak Yadav

RSC Pharm., 2025,2, 437-454

https://doi.org/10.1039/D4PM00323C

 

 

 

Graphical abstract: Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisation

Development of solid drug nanoparticle dispersions for pulmonary delivery of niclosamide and nitazoxanide via vibrating mesh nebulisation

Catherine Unsworth, Andrew B. Dwyer, Alison C. Savage, James J. Hobson, Jonathan Massam, Tom O. McDonald, Paul Curley, Andrew Owen, Andrew O’Sullivan, Ronan MacLoughlin and Steve P. Rannard

RSC Pharm., 2025,2, 517-526

https://doi.org/10.1039/D5PM00006H

 

 

Graphical abstract: Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats

Artesunate-loaded bilosomes with enhanced oral bioavailability: in silico and in vitro study against Leishmania donovani promastigotes and in vivo pharmacokinetic assessment in rats

Hitesh Wankhede, Sudha Madhavi Penumaka, Debabrata Mandal, Supada Rojatkar, Vinod Gaikwad and Sharvil Patil

RSC Pharm., 2025,2, 541-552

https://doi.org/10.1039/D5PM00025D

 

 

 

These articles and our future publications are free to access by anyone.

Start reading now

 RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.

Comments Off on RSC Pharmaceutics Volume 2, Issue 3

4th South Florida Translational Research Symposium 2025- RSC Pharmaceutics poster prize winners

29 Apr 2025
By .

The 4th South Florida Translational Research symposium recently took place at Florida International University, USA, on the 10th and 11th of April 2025. The symposium featured highly relevant plenary talks in neuro-oncology, genomics, cardiopulmonary, and drug discovery and delivery. Our RSC Pharmaceutics Editorial Member, Dr Heidi Mansour attended and supported this conference, and RSC Pharmaceutics sponsored four poster prizes.

We are delighted that the symposium was a success and we would like to wish a huge congratulations to the poster prize winners!

Undergraduate poster winner: Michael Futo (Indian River State College)

Graduate poster winners (tied): Mustapha Olatunji (Florida International University) and Andy Tavel (Florida International University)

Postdoctoral poster winner: Prakash Chaudhari (Florida International University)

RSC Pharmaceutics Undergraduate poster prize winner: Michael Futo (Indian River State College)

RSC Pharmaceutics Graduate poster prize winner: Mustapha Olatunji (Florida International University)

RSC Pharmaceutics Graduate poster prize winner: Andy Tavel (Florida International University)

RSC Pharmaceutics Postdoctoral poster prize winner: Prakash Chaudhari (Florida International University)

The journal is delighted to provide support for this terrific work in such an important area of research.

RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery.

Sign up for email alerts and submit your manuscript.

 

Comments Off on 4th South Florida Translational Research Symposium 2025- RSC Pharmaceutics poster prize winners

« Older Entries